Fact checked by Vivianna ShieldsMedically reviewed by Sanja Jelic, MDA lingering cough after COVID-19 affects nearly 5% of ...

Trevi Therapeutics has announced that its Phase IIb CORAL trial of Haduvio in treating idiopathic pulmonary fibrosis (IPF) ...

Spotting chronic cough, unintended weight loss, recurrent infections, persistent fatigue, and difficulty swallowing early can ...

Background: Children presenting with chronic cough are common to the primary care physicians, but data on the etiology are scant. Methods: We evaluated 40 children (age range, 5 to 12 years ...

Trevi Therapeutics' CORAL trial progresses unchanged after a positive SSRE review, with topline results for chronic cough in ...

Millions suffering from a chronic cough could have their debilitating symptoms relieved by a new treatment, according to a study. Up to 10% of adults worldwide experience symptoms with no clear ...

Two trials of a new drug have shown that at low doses, it can ease the often distressing symptoms of chronic cough with minimal side effects. Principle researcher Jacky Smith, a Professor of ...

The world’s first phase three trials of a new drug have shown that it can ease the often distressing symptom of chronic cough with few side effects. The two Phase 3, randomised, double blind 52-week ...

MSD will have to return to the drawing board to chart a course for US approval of its chronic cough treatment gefapixant. The FDA has declined to approve the drug for a second time, saying the ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

A dog struck down with a chronic cough after inhaling grass was saved when his owners noticed he wasn’t 'singing along' to Shania Twain. Five-year-old Border Collie Jax loves howling to the ...